The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial
磷脂酰丝氨酸靶向抗体 Bavituximab 联合 Pembrolizumab 治疗不可切除的肝细胞癌：一项 2 期临床试验
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-46542-y
David Hsiehchen #, Muhammad S Beg #, Radhika Kainthla, Jay Lohrey, Syed M Kazmi, Leticia Khosama, Mary Claire Maxwell, Heather Kline, Courtney Katz, Asim Hassan, Naoto Kubota, Ellen Siglinsky, Anil K Pillai, Hagop Youssoufian, Colleen Mockbee, Kerry Culm, Mark Uhlik, Laura Benjamin, Rolf A Brekken,
